Skip to main content
Clinical Trials/NL-OMON53064
NL-OMON53064
Recruiting
Not Applicable

Zimmer Maxera acetabular system in total hip arthroplasty: a multi-center, prospective, non-controlled post marktet clinical follow-up study - Maxera study

Zimmer Biomet GmbH0 sites25 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Zimmer Biomet GmbH
Enrollment
25
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Zimmer Biomet GmbH

Eligibility Criteria

Inclusion Criteria

  • Patient is 18 to 75 years of age, inclusive.
  • Patient is skeletally mature.
  • Patient qualifies for primary unilateral or simultaneous bilateral total hip
  • arthroplasty
  • (THA) based on physical exam and medical history including at least one of the
  • o Osteoarthritis
  • o Avascular necrosis (AVN)
  • o Inflammatory arthritis
  • o Rheumatoid arthritis with adequate bone quality
  • o Post\-traumatic arthritis

Exclusion Criteria

  • The patient is:
  • o A prisoner
  • o Mentally incompetent or unable to understand what participation in the study
  • o A known alcohol or drug abuser
  • o Anticipated to be non\-compliant
  • The patient has a neuromuscular disorder, vascular disorder or other
  • condition that
  • could contribute to prosthesis instability, prosthesis fixation failure, or
  • complications in
  • postoperative care.

Outcomes

Primary Outcomes

Not specified

Similar Trials